Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development

Peroxiredoxin IV (Prx4), a typical two-cysteine-containing member of the peroxidase family, functions as an antioxidant to maintain cellular redox homeostasis through the reduction of reactive oxygen species (ROS) via cycles of oxidation–reduction reactions. Under oxidative stress, all Prxs includin...

Full description

Bibliographic Details
Main Authors: Pratik Thapa, Hong Jiang, Na Ding, Yanning Hao, Aziza Alshahrani, Eun Y. Lee, Junichi Fujii, Qiou Wei
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/12/3/677
_version_ 1827751603047759872
author Pratik Thapa
Hong Jiang
Na Ding
Yanning Hao
Aziza Alshahrani
Eun Y. Lee
Junichi Fujii
Qiou Wei
author_facet Pratik Thapa
Hong Jiang
Na Ding
Yanning Hao
Aziza Alshahrani
Eun Y. Lee
Junichi Fujii
Qiou Wei
author_sort Pratik Thapa
collection DOAJ
description Peroxiredoxin IV (Prx4), a typical two-cysteine-containing member of the peroxidase family, functions as an antioxidant to maintain cellular redox homeostasis through the reduction of reactive oxygen species (ROS) via cycles of oxidation–reduction reactions. Under oxidative stress, all Prxs including Prx4 are inactivated as their catalytic cysteines undergo hyperoxidation, and hyperoxidized two-cysteine Prxs can be exclusively repaired and revitalized through the reduction cycle catalyzed by sulfiredoxin (Srx). Previously, we showed that Prx4 is a preferred substrate of Srx, and knockout of Srx in mice leads to resistance to azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon carcinogenesis. To further understand the significance of the Srx/Prx4 axis in colorectal cancer development, Prx4<sup>−/−</sup> mice were established and subjected to standard AOM/DSS protocol. Compared with wildtype littermates, mice with Prx4<sup>−/−</sup> genotype had significantly fewer and smaller tumors. Histopathological analysis revealed that loss of Prx4 leads to increased cell death through lipid peroxidation and lower infiltration of inflammatory cells in the knockout tumors compared to wildtype. Treatment with DSS alone also showed decreased infiltration of macrophages and lymphocytes in the colon of knockout mice, suggesting a role for Prx4 in inflammatory response. In addition, loss of Prx4 caused alterations in plasma cytokines and chemokines after DSS and AOM/DSS treatments. These findings suggest that loss of Prx4 protects mice from AOM/DSS-induced colon tumorigenesis. Thus, targeting Prx4 may provide novel strategies for colon cancer prevention and treatment.
first_indexed 2024-03-11T07:00:30Z
format Article
id doaj.art-5f56db4d9e34476c8654c39ef27be1bc
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-11T07:00:30Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-5f56db4d9e34476c8654c39ef27be1bc2023-11-17T09:18:13ZengMDPI AGAntioxidants2076-39212023-03-0112367710.3390/antiox12030677Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer DevelopmentPratik Thapa0Hong Jiang1Na Ding2Yanning Hao3Aziza Alshahrani4Eun Y. Lee5Junichi Fujii6Qiou Wei7Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Pathology and Laboratory Medicine, University of Kentucky College of Medicine, Lexington, KY 40506, USADepartment of Biomolecular Function, Yamagata University, Yamagata 990-9585, JapanDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40506, USAPeroxiredoxin IV (Prx4), a typical two-cysteine-containing member of the peroxidase family, functions as an antioxidant to maintain cellular redox homeostasis through the reduction of reactive oxygen species (ROS) via cycles of oxidation–reduction reactions. Under oxidative stress, all Prxs including Prx4 are inactivated as their catalytic cysteines undergo hyperoxidation, and hyperoxidized two-cysteine Prxs can be exclusively repaired and revitalized through the reduction cycle catalyzed by sulfiredoxin (Srx). Previously, we showed that Prx4 is a preferred substrate of Srx, and knockout of Srx in mice leads to resistance to azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon carcinogenesis. To further understand the significance of the Srx/Prx4 axis in colorectal cancer development, Prx4<sup>−/−</sup> mice were established and subjected to standard AOM/DSS protocol. Compared with wildtype littermates, mice with Prx4<sup>−/−</sup> genotype had significantly fewer and smaller tumors. Histopathological analysis revealed that loss of Prx4 leads to increased cell death through lipid peroxidation and lower infiltration of inflammatory cells in the knockout tumors compared to wildtype. Treatment with DSS alone also showed decreased infiltration of macrophages and lymphocytes in the colon of knockout mice, suggesting a role for Prx4 in inflammatory response. In addition, loss of Prx4 caused alterations in plasma cytokines and chemokines after DSS and AOM/DSS treatments. These findings suggest that loss of Prx4 protects mice from AOM/DSS-induced colon tumorigenesis. Thus, targeting Prx4 may provide novel strategies for colon cancer prevention and treatment.https://www.mdpi.com/2076-3921/12/3/677peroxiredoxinsulfiredoxincolorectal cancerredoxoxidative stresstumorigenesis
spellingShingle Pratik Thapa
Hong Jiang
Na Ding
Yanning Hao
Aziza Alshahrani
Eun Y. Lee
Junichi Fujii
Qiou Wei
Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
Antioxidants
peroxiredoxin
sulfiredoxin
colorectal cancer
redox
oxidative stress
tumorigenesis
title Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
title_full Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
title_fullStr Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
title_full_unstemmed Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
title_short Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development
title_sort loss of peroxiredoxin iv protects mice from azoxymethane dextran sulfate sodium induced colorectal cancer development
topic peroxiredoxin
sulfiredoxin
colorectal cancer
redox
oxidative stress
tumorigenesis
url https://www.mdpi.com/2076-3921/12/3/677
work_keys_str_mv AT pratikthapa lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT hongjiang lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT nading lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT yanninghao lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT azizaalshahrani lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT eunylee lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT junichifujii lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment
AT qiouwei lossofperoxiredoxinivprotectsmicefromazoxymethanedextransulfatesodiuminducedcolorectalcancerdevelopment